Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01144338 · COMPLETED
Trial details
- NCT number
- NCT01144338
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-18
- Primary completion
- 2017-04-21
- Enrollment
- 14752
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.